380 related articles for article (PubMed ID: 35283223)
1. Artificial intelligence to bring nanomedicine to life.
Serov N; Vinogradov V
Adv Drug Deliv Rev; 2022 May; 184():114194. PubMed ID: 35283223
[TBL] [Abstract][Full Text] [Related]
2. Artificial intelligence aids in development of nanomedicines for cancer management.
Tan P; Chen X; Zhang H; Wei Q; Luo K
Semin Cancer Biol; 2023 Feb; 89():61-75. PubMed ID: 36682438
[TBL] [Abstract][Full Text] [Related]
3. A concise review: the synergy between artificial intelligence and biomedical nanomaterials that empowers nanomedicine.
Hayat H; Nukala A; Nyamira A; Fan J; Wang P
Biomed Mater; 2021 Aug; 16(5):. PubMed ID: 34280907
[TBL] [Abstract][Full Text] [Related]
4. Knowledge Gaps in Generating Cell-Based Drug Delivery Systems and a Possible Meeting with Artificial Intelligence.
Mozafari N; Mozafari N; Dehshahri A; Azadi A
Mol Pharm; 2023 Aug; 20(8):3757-3778. PubMed ID: 37428824
[TBL] [Abstract][Full Text] [Related]
5. Re-envisioning the design of nanomedicines: harnessing automation and artificial intelligence.
Zaslavsky J; Bannigan P; Allen C
Expert Opin Drug Deliv; 2023 Feb; 20(2):241-257. PubMed ID: 36644850
[TBL] [Abstract][Full Text] [Related]
6. Artificial intelligence-powered microfluidics for nanomedicine and materials synthesis.
Liu L; Bi M; Wang Y; Liu J; Jiang X; Xu Z; Zhang X
Nanoscale; 2021 Dec; 13(46):19352-19366. PubMed ID: 34812823
[TBL] [Abstract][Full Text] [Related]
7. Nanomedicine Ex Machina: Between Model-Informed Development and Artificial Intelligence.
Villa Nova M; Lin TP; Shanehsazzadeh S; Jain K; Ng SCY; Wacker R; Chichakly K; Wacker MG
Front Digit Health; 2022; 4():799341. PubMed ID: 35252958
[TBL] [Abstract][Full Text] [Related]
8. Artificial intelligence and machine learning disciplines with the potential to improve the nanotoxicology and nanomedicine fields: a comprehensive review.
Singh AV; Varma M; Laux P; Choudhary S; Datusalia AK; Gupta N; Luch A; Gandhi A; Kulkarni P; Nath B
Arch Toxicol; 2023 Apr; 97(4):963-979. PubMed ID: 36878992
[TBL] [Abstract][Full Text] [Related]
9. Artificial Intelligence and Machine Learning in Computational Nanotoxicology: Unlocking and Empowering Nanomedicine.
Singh AV; Ansari MHD; Rosenkranz D; Maharjan RS; Kriegel FL; Gandhi K; Kanase A; Singh R; Laux P; Luch A
Adv Healthc Mater; 2020 Sep; 9(17):e1901862. PubMed ID: 32627972
[TBL] [Abstract][Full Text] [Related]
10. Merging data curation and machine learning to improve nanomedicines.
Chen C; Yaari Z; Apfelbaum E; Grodzinski P; Shamay Y; Heller DA
Adv Drug Deliv Rev; 2022 Apr; 183():114172. PubMed ID: 35189266
[TBL] [Abstract][Full Text] [Related]
11. Self-driving laboratories: A paradigm shift in nanomedicine development.
Hickman RJ; Bannigan P; Bao Z; Aspuru-Guzik A; Allen C
Matter; 2023 Apr; 6(4):1071-1081. PubMed ID: 37020832
[TBL] [Abstract][Full Text] [Related]
12. Integrating Artificial Intelligence and Nanotechnology for Precision Cancer Medicine.
Adir O; Poley M; Chen G; Froim S; Krinsky N; Shklover J; Shainsky-Roitman J; Lammers T; Schroeder A
Adv Mater; 2020 Apr; 32(13):e1901989. PubMed ID: 31286573
[TBL] [Abstract][Full Text] [Related]
13. Protein Science Meets Artificial Intelligence: A Systematic Review and a Biochemical Meta-Analysis of an Inter-Field.
Villalobos-Alva J; Ochoa-Toledo L; Villalobos-Alva MJ; Aliseda A; Pérez-Escamirosa F; Altamirano-Bustamante NF; Ochoa-Fernández F; Zamora-Solís R; Villalobos-Alva S; Revilla-Monsalve C; Kemper-Valverde N; Altamirano-Bustamante MM
Front Bioeng Biotechnol; 2022; 10():788300. PubMed ID: 35875501
[TBL] [Abstract][Full Text] [Related]
14. Biomaterialomics: Data science-driven pathways to develop fourth-generation biomaterials.
Basu B; Gowtham NH; Xiao Y; Kalidindi SR; Leong KW
Acta Biomater; 2022 Apr; 143():1-25. PubMed ID: 35202854
[TBL] [Abstract][Full Text] [Related]
15. A review on utilizing machine learning technology in the fields of electronic emergency triage and patient priority systems in telemedicine: Coherent taxonomy, motivations, open research challenges and recommendations for intelligent future work.
Salman OH; Taha Z; Alsabah MQ; Hussein YS; Mohammed AS; Aal-Nouman M
Comput Methods Programs Biomed; 2021 Sep; 209():106357. PubMed ID: 34438223
[TBL] [Abstract][Full Text] [Related]
16. Current understanding of biological interactions and processing of DNA origami nanostructures: Role of machine learning and implications in drug delivery.
Singh M; Sharma D; Garg M; Kumar A; Baliyan A; Rani R; Kumar V
Biotechnol Adv; 2022 Dec; 61():108052. PubMed ID: 36307050
[TBL] [Abstract][Full Text] [Related]
17. A machine learning approach to identify clinical trials involving nanodrugs and nanodevices from ClinicalTrials.gov.
de la Iglesia D; García-Remesal M; Anguita A; Muñoz-Mármol M; Kulikowski C; Maojo V
PLoS One; 2014; 9(10):e110331. PubMed ID: 25347075
[TBL] [Abstract][Full Text] [Related]
18. Emerging Directions for Carbon Capture Technologies: A Synergy of High-Throughput Theoretical Calculations and Machine Learning.
Lei Q; Li L; Chen H; Wang X
Environ Sci Technol; 2023 Nov; 57(45):17189-17200. PubMed ID: 37917731
[TBL] [Abstract][Full Text] [Related]
19. The Future of Material Scientists in an Age of Artificial Intelligence.
Maqsood A; Chen C; Jacobsson TJ
Adv Sci (Weinh); 2024 May; 11(19):e2401401. PubMed ID: 38477440
[TBL] [Abstract][Full Text] [Related]
20. A review on patient-specific facial and cranial implant design using Artificial Intelligence (AI) techniques.
Memon AR; Li J; Egger J; Chen X
Expert Rev Med Devices; 2021 Oct; 18(10):985-994. PubMed ID: 34404280
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
